Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

4 resultsUpdated October 24, 2026

← Back to article

1

Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux

Experimental Hematology and Oncology 14(1) (2025)

Ye Zhang; Jian‐Ge Qiu; Wei J. Wang; Fan-Li Sun; Xue Wang; Wenjing Liu; Xiaoyu Jia; Hongbin Ji; Lin Wang; Bing‐Hua Jiang

2

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

Annals of Nuclear Medicine 37(7) (2023)

Sajjad Molavipordanjani; Tahoora Mousavi; Alireza Khorrami Moghadam; Fereshteh Talebpour Amiri; Seyed Mohammad Abedi; Seyed Jalal Hosseinimehr

3

A review of recombinant HER3 affibodies with an effective diagnostic view of cancer cells

Journal of drug targeting 33(3) (2024)

Sahar Babaei Khorzoughi; Mehrnoosh Tavakoli; Mojtaba Mortazavi; Zahra Jafarnejad; Abdorrasoul Malekpour; Tara Kopaiee Malek; Farzane Kargar

4

Lapatinib-Based Radioagents for Application in Nuclear Medicine

Applied Sciences 15(20) (2025)

Przemysław Koźmiński; Ewa Gniazdowska